BioLife Solutions Inc.

34.17+0.4700+1.39%Vol 307.35K1Y Perf 232.80%
Apr 16th, 2021 16:00 DELAYED
BID32.84 ASK34.84
Open33.36 Previous Close33.70
Pre-Market- After-Market34.17
 - -  - -%
Target Price
52.14 
Analyst Rating
Strong Buy 1.00
Potential %
52.59 
Finscreener Ranking
★★★★★     64.22
Insiders Trans % 3/6/12 mo.
-100/-100/-100 
Value Ranking
★★★★+     60.73
Insiders Value % 3/6/12 mo.
-100/-100/-100 
Growth Ranking
★★★★+     63.53
Insiders Shares Cnt. % 3/6/12 mo.
-100/-100/-100 
Income Ranking
 —    -
Market Cap1.14B 
Earnings Rating
Buy
Price Range Ratio 52W %
63.66 
Earnings Date
13th May 2021

Today's Price Range

32.5034.41

52W Range

10.0047.97

5 Year PE Ratio Range

-22.00-10.20

Summary:

Sell

Technical Indicators: Sell
Moving Averages: Strong Sell
Performance
1 Week
-5.08%
1 Month
-9.60%
3 Months
-15.27%
6 Months
21.30%
1 Year
232.80%
3 Years
354.39%
5 Years
1 727.27%
10 Years
-

TickerPriceChg.Chg.%
BLFS34.170.47001.39
AAPL134.16-0.3400-0.25
GOOG2 297.761.10000.05
MSFT260.741.24000.48
XOM56.66-0.3200-0.56
WFC43.841.60003.79
JNJ162.241.85001.15
FB306.18-1.6400-0.53
GE13.39-0.1600-1.18
JPM153.301.13000.74
Financial StrengthValueIndustryS&P 500US Markets
6.30
7.40
0.04
0.05
-140.00
Leverage Ratio 1.10
ProfitabilityValueIndustryS&P 500US Markets
57.10
-6.90
3.60
-23.40
-63.72
RevenueValueIndustryS&P 500US Markets
35.93M
1.08
54.89
49.05
Earnings HistoryEstimateReportedSurprise %
Q04 2020-0.02-0.0150.00
Q03 2020-0.02-0.020.00
Q02 20200.00-0.01-
Q01 20200.000.06-
Q04 2019-0.020.00100.00
Q03 20190.010.010.00
Q02 20190.020.04100.00
Q01 20190.030.030.00
Earnings Per EndEstimateRevision %Trend
3/2021 QR0.00--
6/2021 QR0.03200.00Positive
12/2021 FY0.19137.50Positive
12/2022 FY0.5226.83Positive
Next Report Date13th May 2021
Estimated EPS Next Report-
Estimates Count2
EPS Growth Next 5 Years %10.00
Volume Overview
Volume307.35K
Shares Outstanding33.40M
Trades Count4.03K
Dollar Volume8.89M
Avg. Volume309.62K
Avg. Weekly Volume234.74K
Avg. Monthly Volume421.31K
Avg. Quarterly Volume307.57K

BioLife Solutions Inc. (NASDAQ: BLFS) stock closed at 34.17 per share at the end of the most recent trading day (a 1.39% change compared to the prior day closing price) with a volume of 307.80K shares and market capitalization of 1.14B. Is a component of indices and it is traded on NASDAQ exchange. The company belongs in the Medical Devices & Instruments industry, Healthcare sector and employs 158 people. BioLife Solutions Inc. CEO is Michael Rice.

The one-year performance of BioLife Solutions Inc. stock is 232.8%, while year-to-date (YTD) performance is -14.34%. BLFS stock has a five-year performance of 1727.27%. Its 52-week range is between 10 and 47.97, which gives BLFS stock a 52-week price range ratio of 63.66%

BioLife Solutions Inc. currently has a PE ratio of -45.30, a price-to-book (PB) ratio of 5.83, a price-to-sale (PS) ratio of 32.36, a price to cashflow ratio of 147.10, a PEG ratio of 2.32, a ROA of 1.59%, a ROC of 5.41% and a ROE of 2.11%. The company’s profit margin is -63.72%, its EBITDA margin is 3.60%, and its revenue ttm is $35.93 Million , which makes it $1.08 revenue per share.

Of the last four earnings reports from BioLife Solutions Inc., there were 2 positive earnings surprise and 1 negative earnings surprise. The company has EPS estimate of $0.00 for the next earnings report. BioLife Solutions Inc.’s next earnings report date is 13th May 2021.

The consensus rating of Wall Street analysts for BioLife Solutions Inc. is Strong Buy (1), with a target price of $52.14, which is +52.59% compared to the current price. The earnings rating for BioLife Solutions Inc. stock is Buy (calculated from actual period earnings estimates revision (80% weight) and previous period earnings surprise (20% weight)).

BioLife Solutions Inc. has a dividend yield of -% with a dividend per share of $- and a payout ratio of -%.

BioLife Solutions Inc. has a Sell technical analysis rating based on Technical Indicators (ADX : 13.22, ATR14 : 2.44, CCI20 : -119.30, Chaikin Money Flow : -0.19, MACD : -1.82, Money Flow Index : 59.37, ROC : -4.98, RSI : 37.38, STOCH (14,3) : 30.36, STOCH RSI : 0.75, UO : 40.18, Williams %R : -69.64), Simple Moving Averages and Exponential Moving Averages.

Aggregated Insider Trades of BioLife Solutions Inc. in the last 12-months were: Aby J. Mathew (Option Excercise at a value of $218 561), Aby J. Mathew (Sold 186 960 shares of value $5 289 704 ), Andrew G. Hinson (Sold 5 000 shares of value $207 475 ), James Mathers (Sold 242 shares of value $4 083 ), Joseph Schick (Option Excercise at a value of $9 500), Joseph Schick (Sold 6 250 shares of value $207 000 ), Karen Foster (Option Excercise at a value of $53 572), Karen Foster (Sold 48 004 shares of value $1 849 446 ), Marcus Schulz (Sold 9 516 shares of value $339 690 ), Michael Rice (Option Excercise at a value of $538 684), Michael Rice (Sold 318 906 shares of value $7 839 068 ), Raymond Wayne Cohen (Sold 5 625 shares of value $182 531 ), Roderick De Greef (Option Excercise at a value of $107 100), Roderick De Greef (Sold 79 089 shares of value $2 893 446 ), Thomas Girschweiler (Option Excercise at a value of $14 669 842), Thomas Girschweiler (Sold 5 748 102 shares of value $105 531 770 ), Todd Berard (Option Excercise at a value of $63 076), Todd Berard (Sold 44 877 shares of value $1 713 104 ), Walter Villiger (Option Excercise at a value of $9 404 252), Walter Villiger (Sold 2 261 614 shares of value $61 763 331 )

Analyst RatingsCurrent1 M ago3 M ago
Strong Buy
9 (100.00 %)
9 (100.00 %)
9 (100.00 %)
Moderate Buy
0 (0.00 %)
0 (0.00 %)
0 (0.00 %)
Hold
0 (0.00 %)
0 (0.00 %)
0 (0.00 %)
Moderate Sell
0 (0.00 %)
0 (0.00 %)
0 (0.00 %)
Strong Sell
0 (0.00 %)
0 (0.00 %)
0 (0.00 %)
Summary RatingStrong Buy
1.00
Strong Buy
1.00
Strong Buy
1.00

BioLife Solutions Inc.

BioLife Solutions Inc is active in the healthcare segment. The company is engaged in the developing, manufacturing and marketing a portfolio of biopreservation tools and services for cells, tissues and organs, including clinical grade cell and tissue hypothermic storage and cryopreservation freeze media and a related cloud, hosted biologistics cold chain management application for shippers. The company's product offerings include hypothermic storage and cryopreservation freeze media products for cells, tissues, and organs.

CEO: Michael Rice

Telephone: +1 425 402-1400

Address: 3303 Monte Villa Parkway, Bothell 98021, WA, US

Number of employees: 158

Bearish or Bullish?
WeekMonthThree MonthsSix Months

Bearish Bullish

100%0%

Bearish Bullish

64%36%

Bearish Bullish

48%52%

Bearish Bullish

50%50%

News

Stocktwits